Insulet (PODD)

• Market cap: $22.5B
• 1 day: -1.11%
• 5 days: 1.98%
• 1 month: 2.03%
• 3 months: 5.36%
• 6 months: 21%
• Year to date: 24.52%
• 1 year: 30.55%
• 5 years: 25.26%
• 10 years: 762.98%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 3,900